Atlas Trials

Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis

Clinical trial NCT03000660 · TERMINATED

Trial details

NCT number
NCT03000660
Sponsor
Tufts Medical Center
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
AL Amyloidosis
Start date
2017-01-01
Primary completion
2019-10-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.